Trial NCT03993379

View at ClinicalTrials.gov 
Org. Study IDs: CTMX-M-072-002

Last trial update was posted on 2021-12-01

MeSH Interventions

Ipilimumab

MeSH Conditions

Melanoma Neoplasms

Other Conditions

Solid Tumor Unresectable or Metastatic Melanoma

Stopping Reasons

Sponsor's Decision

Limitations And Caveats

Due to developmental strategic reasons and slow enrollment because of the COVID-19 pandemic, the study was terminated early. Three subjects were enrolled, all in Cohort A2. The last subject observation for this study was on 21 May 2020. Since the study terminated early, a statistical analysis plan was not generated.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID